Gene · 10491
Papers1,478
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,478
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sharing the Same Reality, Healthy Relations Between Colleagues at Work: A Meta-Synthesis. | SAGE Open Nurs | 2023 | 37854790 | PubTator, text mining | PubMed |
| New insights of miRNA molecular mechanisms in breast cancer brain metastasis and therapeutic targets. | Noncoding RNA Res | 2023 | 37818447 | PubTator, text mining | PubMed |
| A high-throughput Gaussia luciferase reporter assay for screening potential gasdermin E activators against pancreatic cancer. | Acta Pharm Sin B | 2023 | 37799380 | PubTator, text mining | PubMed |
| Precise Orchestration of Gasdermins' Pore-Forming Function by Posttranslational Modifications in Health and Disease. | Int J Biol Sci | 2023 | 37781519 | PubTator, text mining | PubMed |
| The role of heat shock proteins in the pathogenesis of heart failure (Review). | Int J Mol Med | 2023 | 37772383 | PubTator, text mining | PubMed |
| Current Status of Next-Generation Sequencing in Bone Genetic Diseases. | Int J Mol Sci | 2023 | 37762102 | PubTator, text mining | PubMed |
| An Examination of Subjective and Objective Measures of Stress in Tactical Populations: A Scoping Review. | Healthcare (Basel) | 2023 | 37761712 | PubTator, text mining | PubMed |
| Unraveling the Role of Hepatic PGC1α in Breast Cancer Invasion: A New Target for Therapeutic Intervention? | Cells | 2023 | 37759533 | PubTator, text mining | PubMed |
| Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma. | Cancer Cell Int | 2023 | 37749554 | PubTator, text mining | PubMed |
| Spatiotemporal, optogenetic control of gene expression in organoids. | Nat Methods | 2023 | 37735569 | PubTator, text mining | PubMed |
| Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients. | Orphanet J Rare Dis | 2023 | 37730650 | PubTator, text mining | PubMed |
| AFsample: improving multimer prediction with AlphaFold using massive sampling. | Bioinformatics | 2023 | 37713472 | PubTator, text mining | PubMed |
| Novel splice site variant of TMEM38B in osteogenesis imperfecta type XIV. | Hum Genome Var | 2023 | 37696855 | PubTator, text mining | PubMed |
| Age and liver graft: a systematic review with meta-regression. | Updates Surg | 2023 | 37695503 | PubTator, text mining | PubMed |
| Dental anomalies in individuals with osteogenesis imperfecta: a systematic review and meta-analysis of prevalence and comparative studies. | J Appl Oral Sci | 2023 | 37672427 | PubTator, text mining | PubMed |
| The quality of life in Alzheimer's disease is not associated with handgrip strength but with activities of daily living-a composite study from 28 European countries. | BMC Geriatr | 2023 | 37667196 | PubTator, text mining | PubMed |
| Expression patterns and immunological characterization of PANoptosis -related genes in gastric cancer. | Front Endocrinol (Lausanne) | 2023 | 37664853 | PubTator, text mining | PubMed |
| SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication. | Sci Rep | 2023 | 37640791 | PubTator, text mining | PubMed |
| Integrating Network Pharmacology and Experimental Validation to Explore the Effects and Mechanisms of Qinghao Biejia Decoction and Its Active Compound Artemisinin B Against Non-Small-Cell Lung Cancer. | Drug Des Devel Ther | 2023 | 37637262 | PubTator, text mining | PubMed |
| Probiotic-Derived Bioactive Compounds in Colorectal Cancer Treatment. | Microorganisms | 2023 | 37630458 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10491/papers?page=9